Ultrasound-guided positioning of totally implantable access port systems: a single-center experience

Applying Totally Implantable Venous Access Devices (TIVAD) in Children: the First Iranian Experience

Safety of a Totally Implantable Central Venous Port System with Percutaneous Subclavian Vein Access

BACKGROUND The role of totally implantable central venous port (TICVP) system is increasing. Implantation performed by radiologist with ultrasound-guided access of vein and fluoroscope-guided positioning of catheter is widely accepted nowadays. In this article, we summarized our experience of TICVP system by surgeon and present the success and complication rate of this surgical method. MATERI...

Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.

BACKGROUND Totally Implantable Venous Access Port Systems (TIVAPS) are widely used in oncology, but complications are frequent, sometimes necessitating device removal and consequently delays in chemotherapy. The aim of this study was to investigate possible risk factors for morbidity. METHODS A total of 815 consecutive cancer patients (median age: 56.2 years [0.8-85.2]; 522 female) were enrol...

Fetal Echocardiography Indications: A Single- Center Experience

Background Congenital heart disease (CHD) is the most common lethal congenital anomaly. Early diagnosis of CHD by fetal echocardiography based on maternal and fetal indications is important and lifesaving. The aim of study was to assess the referral aspects of pregnant women to pediatric cardiologist. Materials and Methods This was a retrospective cross-sectional study on 250 documents of refer...

Retrospective evaluation of totally implantable venous access port devices: early and late complications.

PURPOSE The role totally implantable vascular devices (TIVAD) have an important role in providing care to cancer patients who require continuous or frequent venous access route either for their primary or supportive care treatments. This retrospective study aimed to analyze the efficacy of TIVAD and device-related complications. METHODS A total of 324 consecutive patients (185 male,139 female...